http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9a55c66a7f9a3c04729295c13e02558c
Outgoing Links
Predicate | Object |
---|---|
family-name | Freed |
name | Eric O. Freed Eric O Freed |
given-name | Eric O Eric O. |
organization-name | Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute-Frederick, Frederick, MD 21702; Laboratory of Medicinal Chemistry, CCR, NCI-Frederick, NIH, Bldg. 376 Boyles St., Frederick, Maryland 21702, Protein Chemistry Laboratory, SAIC-Frederick, Inc., Frederick, Maryland 21702, HIV Drug Resistance Program, CCR, NCI-Frederick, Frederick, Maryland 21702, U.S. Army Medical Research Institute for Infectious Diseases, Frederick, Maryland 21702 HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702 Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland 21702-1201 Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute at Frederick, Frederick, Maryland 21702, United States Virus–Cell Interaction Section, HIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD 21702; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases,2 Bethesda, Maryland 20892, and Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0460,1 and Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute at Frederick, Frederick, Maryland 21702-1201 Department of Molecular and Cell Biology, The Pennsylvania State University, University Park, Pennsylvania 16802 Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA The author is at the Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0460, USA. HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland 21702 Virus‐Cell Interaction Section, HIV Drug Resistance ProgramNational Cancer InstituteFrederickMarylandUSA The Virus–Cell Interaction Section HIV Dynamics and Replication Program National Cancer Institute Frederick MD 21701 USA Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Center for Cancer Research, Frederick, Maryland, USA Virus-Cell Interaction Section, HIV Drug Resistance Program, NCI-Frederick, Frederick, Maryland 21702 HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland 21702, United States Virus-Cell Interaction Section, HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0460 Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD, USA. Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, USA HIV Drug Resistance Program, CCR, NCI-Frederick, Frederick, Maryland 21702, United States Laboratory of Molecular Microbiology,2 National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892; Virus-Cell Interaction Section, HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA. Electronic address: efreed@nih.gov. Virus–Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702; Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, and Image Analysis Laboratory, Research Technology Program, SAIC-Frederick, National Cancer Institute, Frederick, MD 21702-1201 Virus-Cell Interaction Section, HIV Dynamics and Replication Program, National Cancer Institute, Frederick, Frederick, MD 21702, USA. *Virus–Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute–Frederick, Frederick, MD 21702; Virus–Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702 Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0460; and Department of Pathology, George Washington University Medical Center, Washington, DC 20037 Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland 21702 Center of Cancer Research Nanobiology Program and Virus-Cell Interaction Section of the HIV Drug Resistance Program, Center of Cancer Research, Basic Research Program and Laboratory of Proteomics & Analytical Technologies, Advanced Technology Program, SAIC-Frederick Inc., National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702 Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland2 Virus–Cell Interaction Section, HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702; and Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201 Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892 Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201, USA. Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 4, Room 307, 9000 Rockville Pike, Bethesda, MD 20892-0460 Virus–Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702-1201 Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702 Virus-Cell Interaction Section, HIV Drug Resistance Program Virus-Cell Interaction Section, HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA. Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0460 Virus-Cell Interaction Section, HIV-1 Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute-Frederick, Frederick, MD 21702 Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0460 HIV Drug Resistance Program, National Cancer Institute at Frederick, Frederick, Maryland 21702 Virus-Cell Interaction Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA. HIV Dynamics and Replication Program, NCI, Frederick, MD, 21702, USA. Virus-Cell Interaction Section, HIV Drug Resistance Program, Center for Cancer Research, National Cancer Institute, Frederick, Maryland, USA Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland. Virus–Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702 6 Virus-Cell Interaction Section, National Cancer Institute, Frederick, Maryland, USA Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute at Frederick, Frederick, Maryland Virus-Cell Interaction Section, HIV Drug Resistance Program, National Cancer Institute, Frederick, MD 21702-1201 HIV Dynamics and Replication, National Cancer Institute, Frederick, MD, United States Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-04603 |
Incoming Links
Total number of triples: 242.